Skip to main content

M-tron Industries, Inc.

For the period ended Dec 31, 2024. Filed Mar 27, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 27, 2025

MPTI$63.95+6.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Stock-Based Compensation

7.** Stock-Based Compensation

In connection with the Separation, the Company's board of directors (the "Board") approved the Amended and Restated2022 Incentive Plan (the*"2022* Plan"), including the authority to issue 500,000 shares of common stock pursuant to the2022 Plan. The2022 Plan is the only long-term plan under which equity compensation* maybe awarded to employees, advisors and members of the Board aligning their interest with those of stockholders. As of December 31, 2024*,255,230 shares remained available for future issuance under the2022 Plan.

The following table summarizes stock-based compensation expense, which includes expenses related to awards granted under the Plan for the period indicated:

Year Ended December 31,
(in thousands, except share data)20242023
Restricted stock awards$636$409
Stock options—2,013
Total$636$2,422

Restricted Stock Awards

Restricted stock awards are measured at a value equal to the market price of the Company's common stock on the date of grant which is recognized over the service period of the award.

A summary of the Company's restricted stock awards for the year ended* December 31, 2024* follows:

(in thousands, except share data)Number of SharesWeighted Average Grant Date Fair ValueAggregate Grant Date Fair value
Balance as of December 31, 202379,896$11.20$895
Granted32,54838.661,258
Vested(42,320)(12.93)(547)
Balance as of December 31, 202470,124$22.90$1,606

As of* December 31, 2024*, there was $1,371 of total unrecognized compensation cost related to nonvested shares granted. The cost is expected to be recognized over a weighted-average period of 1.9 years.

Stock Options

The following table provides a rollforward of stock option activity:

(in thousands, except share data)Number of Options OutstandingWeighted Average Exercise PriceWeighted Average Grant Date Fair ValueWeighted Average Remaining Term (in years)Aggregate Intrinsic Value
Outstanding and exercisable as of December 31, 2023193,010$34.90$10.632.9$219
Granted———
Exercised(92,296)(33.64)(10.05)
Forfeited(2,700)(36.06)(10.98)
Outstanding and exercisable as of December 31, 202498,014$36.06$10.982.0$1,212
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.